Vitronectin

Vitronectin

Nuwacell^® Vitronectin（RP01002）, originally developed by Nuwacell Biotechnologies Co., Ltd. is a recombinant human protein with defined formulation and no foreign components, which can provide a defined surface for feeder-free culture of human pluripotent stem cells (hPSC). Vitronectin is an effective replacement for Corning Matrigel, human plasma derived vitronectin and standard basement membrane extract (BME).

Advantage

• ✔ Chemical defined, Xeno-free.
• ✔ Easy to use (Use at room temperature).
• ✔ Good compatibility.

  Product manual download

Contents	Amount	Cat. No.	Storage
Nuwacell® Vitronectin	1mg (2mL)	RP01002	-20°C~-80℃

1、Cell morphology

 

Nuwacell^® Vitronectin supports hiPSC attachment and survival well when used in conjunction with ncEpic hPSC Medium.

The morphology of hiPSC (P20). cultured at day 1 (left panel), 2 (middle panel), and 3 (right panel) after passaging. Scale bar, 200 μm.

Citations & References

• Base editing-mediated splicing correction therapy for spinal muscular atrophy

  2020. Xiang Lin, et al.. Cell Research(IF 46.297).
• Embryonic Stem Cell Derived Small Extracellular Vesicles Modulate Regulatory T Cells to Protect against Ischemic Stroke

  2020. Yuguo Xia, et al.. ACS Nano(IF 18.027).
• ESC‐sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia

  2020. Guowen Hu, et al.. Advanced Science(IF 17.521).

View all references

Please call 400 888 3920 for more references.